Researchers have identified the brain cells responsible for the weight-loss effects of semaglutide without triggering its undesirable side effects. This discovery paves the way for more targeted ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

But like any treatment, they come with potential risks. If you or a loved one is taking semaglutide or a related GLP-1 RA, especially at an older age, it’s wise to: Ongoing research will help ...

Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

An international clinical trial, led in the UK by Swansea’s Joint Clinical Research Facility (JCRF), has found that ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

A new study has found a significant association between the use of GLP-1s such as Ozempic and Wegovy with a higher risk of developing a serious eye condition in patients with diabetes. Here are four t ...

Ozempic is FDA-approved for treating type 2 diabetes – but could it also help with other conditions like PCOS Read on to find out what an expert says ...

Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...